Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $438.83 million. The enterprise value is $449.04 million.
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 52.62 million shares outstanding. The number of shares has increased by 14.39% in one year.
| Shares Outstanding | 52.62M |
| Shares Change (YoY) | +14.39% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 6.28% |
| Owned by Institutions (%) | 31.75% |
| Float | 49.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.83 |
| Forward PS | 8.28 |
| PB Ratio | 10.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 1.83.
| Current Ratio | 2.00 |
| Quick Ratio | 1.91 |
| Debt / Equity | 1.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.86 |
Financial Efficiency
Return on equity (ROE) is -132.32% and return on invested capital (ROIC) is -53.66%.
| Return on Equity (ROE) | -132.32% |
| Return on Assets (ROA) | -37.41% |
| Return on Capital (ROIC) | -53.66% |
| Revenue Per Employee | $343,319 |
| Profits Per Employee | -$968,203 |
| Employee Count | 69 |
| Asset Turnover | 0.19 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVRA has paid $177,000 in taxes.
| Income Tax | 177,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +98.10% in the last 52 weeks. The beta is 1.95, so ZVRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +98.10% |
| 50-Day Moving Average | 7.59 |
| 200-Day Moving Average | 6.05 |
| Relative Strength Index (RSI) | 57.81 |
| Average Volume (20 Days) | 948,523 |
Short Selling Information
The latest short interest is 4.74 million, so 9.01% of the outstanding shares have been sold short.
| Short Interest | 4.74M |
| Short Previous Month | 3.77M |
| Short % of Shares Out | 9.01% |
| Short % of Float | 9.61% |
| Short Ratio (days to cover) | 3.95 |
Income Statement
In the last 12 months, ZVRA had revenue of $23.69 million and -$66.81 million in losses. Loss per share was -$1.70.
| Revenue | 23.69M |
| Gross Profit | 17.80M |
| Operating Income | -74.80M |
| Pretax Income | -50.87M |
| Net Income | -66.81M |
| EBITDA | -70.83M |
| EBIT | -74.80M |
| Loss Per Share | -$1.70 |
Full Income StatementBalance Sheet
The company has $49.26 million in cash and $59.47 million in debt, giving a net cash position of -$10.21 million or -$0.19 per share.
| Cash & Cash Equivalents | 49.26M |
| Total Debt | 59.47M |
| Net Cash | -10.21M |
| Net Cash Per Share | -$0.19 |
| Equity (Book Value) | 32.48M |
| Book Value Per Share | 0.77 |
| Working Capital | 30.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$56.06 million and capital expenditures -$244,000, giving a free cash flow of -$56.30 million.
| Operating Cash Flow | -56.06M |
| Capital Expenditures | -244,000 |
| Free Cash Flow | -56.30M |
| FCF Per Share | -$1.07 |
Full Cash Flow StatementMargins
Gross margin is 75.13%, with operating and profit margins of -315.77% and -282.01%.
| Gross Margin | 75.13% |
| Operating Margin | -315.77% |
| Pretax Margin | -281.27% |
| Profit Margin | -282.01% |
| EBITDA Margin | -299.00% |
| EBIT Margin | n/a |
| FCF Margin | -163.97% |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.39% |
| Shareholder Yield | -14.39% |
| Earnings Yield | -15.22% |
| FCF Yield | -12.83% |
Analyst Forecast
The average price target for ZVRA is $21.00, which is 151.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 151.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 60.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 0.0625:1.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0625:1 |
Scores
ZVRA has an Altman Z-Score of -4.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.45 |
| Piotroski F-Score | 2 |